Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance

BACKGROUND: Prostate cancer is the most common cancer in men and second leading cause of cancer-related deaths. Changes in screening guidelines, adoption of active surveillance (AS), and implementation of high-cost technologies have changed treatment costs. Traditional cost-effectiveness studies rel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Urol Open Sci
Autors principals: Magnani, Christopher J., Bievre, Nicolas, Baker, Laurence C., Brooks, James D., Blayney, Douglas W., Hernandez-Boussard, Tina
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Prostate Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751921/
https://ncbi.nlm.nih.gov/pubmed/33367287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euros.2020.11.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars